| Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study WH Bos, GJ Wolbink, M Boers, GJ Tijhuis, N de Vries, ... Annals of the rheumatic diseases 69 (3), 490-494, 2010 | 364 | 2010 |
| Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase MGH Van de Sande, MJH De Hair, C Van Der Leij, PL Klarenbeek, ... Annals of the rheumatic diseases 70 (5), 772-777, 2011 | 279 | 2011 |
| A prediction rule for the development of arthritis in seropositive arthralgia patients LA Van De Stadt, BI Witte, WH Bos, D Van Schaardenburg Annals of the rheumatic diseases 72 (12), 1920-1926, 2013 | 259 | 2013 |
| The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia LA van de Stadt, AR van der Horst, MHMT de Koning, WH Bos, ... Annals of the rheumatic diseases 70 (1), 128-133, 2011 | 196 | 2011 |
| The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study LA van de Stadt, WH Bos, M Meursinge Reynders, H Wieringa, F Turkstra, ... Arthritis research & therapy 12, 1-7, 2010 | 168 | 2010 |
| Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial WH Bos, BAC Dijkmans, M Boers, RJ Van De Stadt, ... Annals of the rheumatic diseases 69 (3), 571-574, 2010 | 159 | 2010 |
| Gene expression profiling in autoantibody‐positive patients with arthralgia predicts development of arthritis LGM van Baarsen, WH Bos, F Rustenburg, TCTM van der Pouw Kraan, ... Arthritis & Rheumatism 62 (3), 694-704, 2010 | 111 | 2010 |
| Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis WH Bos, GM Bartelds, GJ Wolbink, MHMT De Koning, RJ Van De Stadt, ... The Journal of rheumatology 35 (10), 1972-1977, 2008 | 97 | 2008 |
| Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systems J Ursum, WH Bos, RJ van de Stadt, BAC Dijkmans, D van Schaardenburg Arthritis research & therapy 11, 1-6, 2009 | 79 | 2009 |
| Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands WH Bos, A van Tubergen, HE Vonkeman Rheumatology international 41 (3), 565-573, 2021 | 77 | 2021 |
| Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study J Ursum, WH Bos, N van Dillen, BAC Dijkmans, D van Schaardenburg Arthritis research & therapy 12, 1-7, 2010 | 63 | 2010 |
| Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study HG Raterman, A Jamnitski, WF Lems, AE Voskuyl, BAC Dijkmans, ... The Journal of rheumatology 38 (2), 247-251, 2011 | 54 | 2011 |
| IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker … M Vis, WH Bos, G Wolbink, AE Voskuyl, JWR Twisk, R Van de Stadt, ... The Journal of Rheumatology 35 (3), 425-428, 2008 | 50 | 2008 |
| Feasibility of self-monitoring rheumatoid arthritis with a smartphone app: results of two mixed-methods pilot studies BF Seppen, J Wiegel, MJ L'ami, SD dos Santos Rico, FS Catarinella, ... JMIR formative research 4 (9), e20165, 2020 | 47 | 2020 |
| Asynchronous mHealth interventions in rheumatoid arthritis: systematic scoping review BF Seppen, P den Boer, J Wiegel, MM Ter Wee, M van der Leeden, ... JMIR mHealth and uHealth 8 (11), e19260, 2020 | 46 | 2020 |
| Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis WH Bos, LA van de Stadt, A Sohrabian, J Rönnelid, ... Arthritis research & therapy 16, 1-2, 2014 | 46 | 2014 |
| The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels WH Bos, J Ursum, N de Vries, GM Bartelds, GJ Wolbink, MT Nurmohamed, ... Annals of the rheumatic diseases 67 (9), 1347-1350, 2008 | 43 | 2008 |
| Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial L van Boheemen, S Turk, M van Beers-Tas, W Bos, D Marsman, EN Griep, ... RMD open 7 (1), e001591, 2021 | 41 | 2021 |
| Smartphone‐assisted patient‐initiated care versus usual care in patients with rheumatoid arthritis and low disease activity: a randomized controlled trial B Seppen, J Wiegel, MM Ter Wee, D van Schaardenburg, LD Roorda, ... Arthritis & Rheumatology 74 (11), 1737-1745, 2022 | 34 | 2022 |
| Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis WH Bos, GM Bartelds, M Vis, AR Van Der Horst, GJ Wolbink, ... Annals of the rheumatic diseases 68 (4), 558-563, 2009 | 33 | 2009 |
Gertjan WolbinkReade在 reade.nl 的电子邮件经过验证
Gertjan WolbinkReade在 reade.nl 的电子邮件经过验证